Phase 1/2 CLL clinical study

Data was obtained on the efficacy in a phase I/II study investigating multiple injections of CLL-DCV01 in patients with previously treated B-cell chronic lymphocytic leukemia.

This study is fully enrolled (n=9). Efficacy data will be assessed via tumor burden data collected over the next two months. Absolute lymphocyte counts and immunomonitoring data will be compiled by the end of Q1’08.

• organism type
• Homo sapiens

created over 16 years ago (2 March 2009)    last modified over 12 years ago (24 September 2012)   [ RDF ]   [ RelFinder ]